Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

The effectiveness of medication reconciliation to prevent medication error: A systematic review and meta-analysis.

Chiewchantanakit D, Meakchai A, Pituchaturont N, Dilokthornsakul P, Dhippayom T.

Res Social Adm Pharm. 2019 Oct 7. pii: S1551-7411(19)30170-6. doi: 10.1016/j.sapharm.2019.10.004. [Epub ahead of print]

PMID:
31607507
2.

A Real-World Evidence Analysis of Associations Among Costs, Quality of Life, and Disease-Severity Indicators of Alzheimer's Disease in Thailand.

Kongpakwattana K, Dejthevaporn C, Krairit O, Dilokthornsakul P, Mohan D, Chaiyakunapruk N.

Value Health. 2019 Oct;22(10):1137-1145. doi: 10.1016/j.jval.2019.04.1937. Epub 2019 Aug 7.

PMID:
31563256
3.

Glossary for systematic reviews and meta-analyses.

Nagendrababu V, Dilokthornsakul P, Jinatongthai P, Veettil SK, Pulikkotil SJ, Duncan HF, Dummer PMH.

Int Endod J. 2019 Sep 13. doi: 10.1111/iej.13217. [Epub ahead of print] Review.

PMID:
31520403
4.

The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis.

Rabgay K, Waranuch N, Chaiyakunapruk N, Sawangjit R, Ingkaninan K, Dilokthornsakul P.

J Am Pharm Assoc (2003). 2019 Sep 5. pii: S1544-3191(19)30353-X. doi: 10.1016/j.japh.2019.07.015. [Epub ahead of print]

PMID:
31495691
5.

An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand.

Dilokthornsakul P, Kengkla K, Saokaew S, Permsuwan U, Techasaensiri C, Chotpitayasunondh T, Chaiyakunapruk N.

Vaccine. 2019 Jul 26;37(32):4551-4560. doi: 10.1016/j.vaccine.2019.06.015. Epub 2019 Jul 4.

PMID:
31280944
6.

Effects of Non-statin Lipid-Modifying Agents on Cardiovascular Morbidity and Mortality Among Statin-Treated Patients: A Systematic Review and Network Meta-Analysis.

Chaiyasothi T, Nathisuwan S, Dilokthornsakul P, Vathesatogkit P, Thakkinstian A, Reid C, Wongcharoen W, Chaiyakunapruk N.

Front Pharmacol. 2019 May 22;10:547. doi: 10.3389/fphar.2019.00547. eCollection 2019.

7.

Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation.

Dilokthornsakul P, Nathisuwan S, Krittayaphong R, Chutinet A, Permsuwan U.

Heart Lung Circ. 2019 Mar 27. pii: S1443-9506(19)30263-X. doi: 10.1016/j.hlc.2019.02.187. [Epub ahead of print]

PMID:
31000364
8.

Impact of Medication Reviews Delivered by Community Pharmacist to Elderly Patients on Polypharmacy: A Meta-analysis of Randomized Controlled Trials.

Tasai S, Kumpat N, Dilokthornsakul P, Chaiyakunapruk N, Saini B, Dhippayom T.

J Patient Saf. 2019 Mar 26. doi: 10.1097/PTS.0000000000000599. [Epub ahead of print]

PMID:
30920431
9.

The clinical effect of glutathione on skin color and other related skin conditions: A systematic review.

Dilokthornsakul W, Dhippayom T, Dilokthornsakul P.

J Cosmet Dermatol. 2019 Jun;18(3):728-737. doi: 10.1111/jocd.12910. Epub 2019 Mar 20. Review.

PMID:
30895708
10.

The prevalence of MS in the United States: A population-based estimate using health claims data.

Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG; US Multiple Sclerosis Prevalence Workgroup.

Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15. Erratum in: Neurology. 2019 Oct 8;93(15):688.

11.

Incorporating adherence in cost-effectiveness analyses of asthma: a systematic review.

Chongmelaxme B, Chaiyakunapruk N, Dilokthornsakul P.

J Med Econ. 2019 Jun;22(6):554-566. doi: 10.1080/13696998.2019.1572014. Epub 2019 Feb 4.

PMID:
30663455
12.

Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.

Chongmelaxme B, Phisalprapa P, Manthaisong R, Dilokthornsakul P, Chaiyakunapruk N.

Pharmacoeconomics. 2019 Feb;37(2):291. doi: 10.1007/s40273-018-0754-y.

PMID:
30547370
13.

Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand.

Chongmelaxme B, Phisalprapa P, Sawangjit R, Dilokthornsakul P, Chaiyakunapruk N.

Pharmacoeconomics. 2019 Feb;37(2):267-278. doi: 10.1007/s40273-018-0736-0. Erratum in: Pharmacoeconomics. 2018 Dec 13;:.

PMID:
30430467
14.

Effects of an Asthma Self-Management Support Service Provided by Community Pharmacists: A Systematic Review and Meta-Analysis.

Dokbua S, Dilokthornsakul P, Chaiyakunapruk N, Saini B, Krass I, Dhippayom T.

J Manag Care Spec Pharm. 2018 Nov;24(11):1184-1196. doi: 10.18553/jmcp.2018.24.11.1184.

15.

Compliance and persistence with Alzheimer's disease treatment: a retrospective analysis of multiregional hospital databases in Thailand.

Kongpakwattana K, Dilokthornsakul P, Dejthevaporn C, Pattanaprateep O, Chaiyakunapruk N.

J Med Econ. 2018 Oct 24:1-9. doi: 10.1080/13696998.2018.1534739. [Epub ahead of print]

PMID:
30303420
16.

The Effects of Telemedicine on Asthma Control and Patients' Quality of Life in Adults: A Systematic Review and Meta-analysis.

Chongmelaxme B, Lee S, Dhippayom T, Saokaew S, Chaiyakunapruk N, Dilokthornsakul P.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):199-216.e11. doi: 10.1016/j.jaip.2018.07.015. Epub 2018 Jul 25.

PMID:
30055283
17.

Treatment patterns and related clinical consequences in adults with asthma.

Dilokthornsakul P, Thompson AM, Campbell JD.

J Asthma. 2019 Jul;56(7):739-747. doi: 10.1080/02770903.2018.1490749. Epub 2018 Aug 24.

PMID:
29972095
18.

Cultural beliefs, utility values, and health technology assessment.

Mahlich J, Dilokthornsakul P, Sruamsiri R, Chaiyakunapruk N.

Cost Eff Resour Alloc. 2018 Jun 1;16:19. doi: 10.1186/s12962-018-0103-1. eCollection 2018.

19.

Efficacy and safety of Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham for menopausal women: A systematic review of clinical trials and the way forward.

Kongkaew C, Scholfield NC, Dhippayom T, Dilokthornsakul P, Saokaew S, Chaiyakunapruk N.

J Ethnopharmacol. 2018 Apr 24;216:162-174. doi: 10.1016/j.jep.2018.01.028. Epub 2018 Feb 6. Review.

PMID:
29409850
20.

Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation.

Dilokthornsakul P, Patidar M, Campbell JD.

Value Health. 2017 Dec;20(10):1329-1335. doi: 10.1016/j.jval.2017.06.014. Epub 2017 Aug 1.

21.

Economic Evaluation and Budget Impact Analysis of Vaccination against Haemophilus influenzae Type b Infection in Thailand.

Kotirum S, Muangchana C, Techathawat S, Dilokthornsakul P, Wu DB, Chaiyakunapruk N.

Front Public Health. 2017 Nov 20;5:289. doi: 10.3389/fpubh.2017.00289. eCollection 2017.

22.

Clinical effects of Zingiber cassumunar (Plai): A systematic review.

Chongmelaxme B, Sruamsiri R, Dilokthornsakul P, Dhippayom T, Kongkaew C, Saokaew S, Chuthaputti A, Chaiyakunapruk N.

Complement Ther Med. 2017 Dec;35:70-77. doi: 10.1016/j.ctim.2017.09.009. Epub 2017 Oct 7. Review.

PMID:
29154071
23.

Asthma Cost-Effectiveness Analyses: Are We Using the Recommended Outcomes in Estimating Value?

Kim CH, Dilokthornsakul P, Campbell JD, van Boven JFM.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):619-632. doi: 10.1016/j.jaip.2017.07.028. Epub 2017 Sep 28.

PMID:
28967548
24.

Effects of Centella asiatica (L.) Urb. on cognitive function and mood related outcomes: A Systematic Review and Meta-analysis.

Puttarak P, Dilokthornsakul P, Saokaew S, Dhippayom T, Kongkaew C, Sruamsiri R, Chuthaputti A, Chaiyakunapruk N.

Sci Rep. 2017 Sep 6;7(1):10646. doi: 10.1038/s41598-017-09823-9.

25.

Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer's perspective.

Permsuwan U, Thavorn K, Dilokthornsakul P, Saokaew S, Chaiyakunapruk N.

J Med Econ. 2017 Sep;20(9):991-999. doi: 10.1080/13696998.2017.1347792. Epub 2017 Jul 11.

PMID:
28649943
26.

The effects of fibrinolytic before referring STEMI patients: A systematic review and meta-analysis.

Mongkhon P, Dilokthornsakul P, Tepwang K, Tapanya K, Sopitprasan C, Chaliawsin P, Saokaew S.

Int J Cardiol Heart Vasc. 2017 Apr 8;15:9-14. doi: 10.1016/j.ijcha.2017.03.003. eCollection 2017 Jun.

27.

Prevention and Control of Multidrug-Resistant Gram-Negative Bacteria in Adult Intensive Care Units: A Systematic Review and Network Meta-analysis.

Teerawattanapong N, Kengkla K, Dilokthornsakul P, Saokaew S, Apisarnthanarak A, Chaiyakunapruk N.

Clin Infect Dis. 2017 May 15;64(suppl_2):S51-S60. doi: 10.1093/cid/cix112. Review.

PMID:
28475791
28.

Value of Information in Asia: Concepts, Current Use, and Future Directions.

Dilokthornsakul P, McQueen RB, Chaiyakunapruk N, Spackman E, Watanabe JH, Campbell JD.

Value Health Reg Issues. 2016 May;9:99-104. doi: 10.1016/j.vhri.2015.12.003. Epub 2016 Apr 12.

PMID:
27881269
29.

Comparison of Health Care Utilization and Costs for Patients with Asthma by Severity and Health Insurance in Thailand.

Dilokthornsakul P, Lee TA, Dhippayom T, Jeanpeerapong N, Chaiyakunapruk N.

Value Health Reg Issues. 2016 May;9:105-111. doi: 10.1016/j.vhri.2016.03.001. Epub 2016 Apr 27.

PMID:
27881251
30.

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand.

Permsuwan U, Dilokthornsakul P, Saokaew S, Thavorn K, Chaiyakunapruk N.

Clinicoecon Outcomes Res. 2016 Sep 21;8:521-529. eCollection 2016.

31.

Clinical Effects of Krachaidum ( Kaempferia parviflora): A Systematic Review.

Saokaew S, Wilairat P, Raktanyakan P, Dilokthornsakul P, Dhippayom T, Kongkaew C, Sruamsiri R, Chuthaputti A, Chaiyakunapruk N.

J Evid Based Complementary Altern Med. 2017 Jul;22(3):413-428. doi: 10.1177/2156587216669628. Epub 2016 Sep 30.

32.

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand.

Permsuwan U, Dilokthornsakul P, Thavorn K, Saokaew S, Chaiyakunapruk N.

J Med Econ. 2017 Feb;20(2):171-181. doi: 10.1080/13696998.2016.1238386. Epub 2016 Sep 29.

PMID:
27645706
33.

Does the use of efficacy or effectiveness evidence in cost-effectiveness analysis matter?

Dilokthornsakul P, Chaiyakunapruk N, Campbell JD.

J Asthma. 2017 Jan 2;54(1):17-23. doi: 10.1080/02770903.2016.1193601. Epub 2016 Jun 10. Review.

PMID:
27284904
34.

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand.

Boonlue T, Subongkot S, Dilokthornsakul P, Kongsakon R, Pattanaprateep O, Suanchang O, Chaiyakunapruk N.

Clinicoecon Outcomes Res. 2016 Apr 29;8:127-36. doi: 10.2147/CEOR.S97300. eCollection 2016.

35.

Forecasting US ivacaftor outcomes and cost in cystic fibrosis patients with the G551D mutation.

Dilokthornsakul P, Hansen RN, Campbell JD.

Eur Respir J. 2016 Jun;47(6):1697-705. doi: 10.1183/13993003.01444-2015. Epub 2016 Apr 28.

36.

Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.

Bamrungsawad N, Upakdee N, Pratoomsoot C, Sruamsiri R, Dilokthornsakul P, Dechanont S, Wu DB, Dejthevaporn C, Chaiyakunapruk N.

Clin Drug Investig. 2016 Jul;36(7):557-66. doi: 10.1007/s40261-016-0401-3.

PMID:
27113227
37.

Healthcare utilization and cost of Stevens-Johnson syndrome and toxic epidermal necrolysis management in Thailand.

Dilokthornsakul P, Sawangjit R, Inprasong C, Chunhasewee S, Rattanapan P, Thoopputra T, Chaiyakunapruk N.

J Postgrad Med. 2016 Apr-Jun;62(2):109-14. doi: 10.4103/0022-3859.180571.

38.

Effects of medication adherence on hospitalizations and healthcare costs in patients with schizophrenia in Thailand.

Dilokthornsakul P, Thoopputra T, Patanaprateep O, Kongsakon R, Chaiyakunapruk N.

SAGE Open Med. 2016 Mar 8;4:2050312116637026. doi: 10.1177/2050312116637026. eCollection 2016.

39.

Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials.

Kongwatcharapong J, Dilokthornsakul P, Nathisuwan S, Phrommintikul A, Chaiyakunapruk N.

Int J Cardiol. 2016 May 15;211:88-95. doi: 10.1016/j.ijcard.2016.02.146. Epub 2016 Mar 2. Review.

PMID:
26991555
40.

Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand.

Permsuwan U, Chaiyakunapruk N, Dilokthornsakul P, Thavorn K, Saokaew S.

Appl Health Econ Health Policy. 2016 Jun;14(3):281-92. doi: 10.1007/s40258-016-0228-3.

PMID:
26961276
41.

Multiple sclerosis prevalence in the United States commercially insured population.

Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD.

Neurology. 2016 Mar 15;86(11):1014-21. doi: 10.1212/WNL.0000000000002469. Epub 2016 Feb 17.

42.

Risk Factors of Prescription Opioid Overdose Among Colorado Medicaid Beneficiaries.

Dilokthornsakul P, Moore G, Campbell JD, Lodge R, Traugott C, Zerzan J, Allen R, Page RL 2nd.

J Pain. 2016 Apr;17(4):436-43. doi: 10.1016/j.jpain.2015.12.006. Epub 2015 Dec 22.

PMID:
26721613
43.

Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database.

Win TS, Chaiyakunapruk N, Suwankesawong W, Dilokthornsakul P, Nathisuwan S.

Asian Pac J Allergy Immunol. 2015 Sep;33(3):227-35. doi: 10.12932/AP0556.33.3.2015. Erratum in: Asian Pac J Allergy Immunol. 2016 Mar;34(1):94.

44.

Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network Approach.

Lai EC, Man KK, Chaiyakunapruk N, Cheng CL, Chien HC, Chui CS, Dilokthornsakul P, Hardy NC, Hsieh CY, Hsu CY, Kubota K, Lin TC, Liu Y, Park BJ, Pratt N, Roughead EE, Shin JY, Watcharathanakij S, Wen J, Wong IC, Yang YH, Zhang Y, Setoguchi S.

Epidemiology. 2015 Nov;26(6):815-20. doi: 10.1097/EDE.0000000000000325.

PMID:
26133022
45.

Clinical effects of thai herbal compress: a systematic review and meta-analysis.

Dhippayom T, Kongkaew C, Chaiyakunapruk N, Dilokthornsakul P, Sruamsiri R, Saokaew S, Chuthaputti A.

Evid Based Complement Alternat Med. 2015;2015:942378. doi: 10.1155/2015/942378. Epub 2015 Mar 12. Review.

46.

Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand.

Bamrungsawad N, Chaiyakunapruk N, Upakdee N, Pratoomsoot C, Sruamsiri R, Dilokthornsakul P.

Pharmacoeconomics. 2015 May;33(5):521-31. doi: 10.1007/s40273-015-0269-8.

PMID:
25774016
47.

Quality of reporting of randomised controlled trials of herbal interventions in ASEAN Plus Six Countries: a systematic review.

Pratoomsoot C, Sruamsiri R, Dilokthornsakul P, Chaiyakunapruk N.

PLoS One. 2015 Jan 29;10(1):e108681. doi: 10.1371/journal.pone.0108681. eCollection 2015. Review.

48.

Comparison of Health Care Utilization and Costs for Patietns with Asthma by Severity and Health Insurance in Thailand: Using Generalized Linear Regression Model.

Dilokthornsakul P, Lee TA, Dhippayom T, Jeanpeerapong N, Chaiyakunapruk N.

Value Health. 2014 Nov;17(7):A778. doi: 10.1016/j.jval.2014.08.360. Epub 2014 Oct 26. No abstract available.

49.

Health Care Utilization and Cost of Management in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thailand.

Maenthaisong R, Dilokthornsakul P, Wises K, Chunhasewee S, Rattanapan P, Chaiyakunapruk N.

Value Health. 2014 Nov;17(7):A778. doi: 10.1016/j.jval.2014.08.362. Epub 2014 Oct 26. No abstract available.

50.

Inhaled Anticholinergics and Risk for Acute Urinary Retention: A Case-Crossover and Case-Time-Control Study.

Lin FJ, Joo MJ, Pickard AS, Dilokthornsakul P, Lee TA.

Value Health. 2014 Nov;17(7):A776. doi: 10.1016/j.jval.2014.08.350. Epub 2014 Oct 26. No abstract available.

Supplemental Content

Loading ...
Support Center